ID

13177

Descripción

Idarubicin Versus High Dose Daunorubicin in Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01145846

Link

https://clinicaltrials.gov/show/NCT01145846

Palabras clave

  1. 21/1/16 21/1/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

21 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Acute Myelogenous Leukemia NCT01145846

Eligibility Acute Myelogenous Leukemia NCT01145846

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with previously-untreated acute myeloid leukemia (20% or more of blasts in bone marrow and/or blood; m6 subtype may have less than 20% of blasts.). therapy-related leukemia or leukemia after myelodysplastic syndrome will be included.
Descripción

AML

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023467
15 years old or older, but 65 years or younger
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
adequate performance status (karnofsky score of 50 or more)
Descripción

karnofsky

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
adequate hepatic and renal function (ast, alt, bilirubin and creatinine < 2.5 x upper normal limit). elevation of ast or alt due to hepatic infiltration of leukemic cells will be permitted.
Descripción

hepatic and renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201899
UMLS CUI [4]
C0201836
adequate cardiac function (left ventricular ejection fraction of 45% or more on heart scan or echocardiogram)
Descripción

cardiac function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428772
signed and dated informed consent must be obtained
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with acute promyelocytic leukemia or bcr-abl gene rearrangement
Descripción

APL

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023487
patients with cns leukemia
Descripción

cns leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1332884
patients with primary granulocytic sarcoma without bone marrow involvement
Descripción

granulocytic sarcoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0152276
prior chemotherapy for leukemia or anthracycline treatment for any malignancy. hydroxyurea for reduction of leukemic cell burden before induction chemotherapy will be permitted.
Descripción

chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
presence of significant active infection
Descripción

infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
presence of uncontrolled bleeding
Descripción

bleeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019080
significant cardiovascular disease including myocardial infarction within previous 6 months
Descripción

heart disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018799
any coexisting major illness or organ failure
Descripción

comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
patients with psychiatric disorder or mental deficiency severe as to make compliance with the treatment unlike, and making informed consent impossible
Descripción

patients with psychiatric disorder or mental deficiency severe as to make compliance with the treatment unlike, and making informed consent impossible

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
nursing women, pregnant women, women of childbearing potential who do not want adequate contraception
Descripción

pregnancy or lactation, contraception

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0700589
patients with a diagnosis of prior malignancy unless disease-free for at least 5 years following therapy with curative intent (except curatively treated nonmelanoma skin cancer, in situ carcinoma, or cervical intraepithelial neoplasia)
Descripción

malignancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826

Similar models

Eligibility Acute Myelogenous Leukemia NCT01145846

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
AML
Item
patients with previously-untreated acute myeloid leukemia (20% or more of blasts in bone marrow and/or blood; m6 subtype may have less than 20% of blasts.). therapy-related leukemia or leukemia after myelodysplastic syndrome will be included.
boolean
C0023467 (UMLS CUI [1])
age
Item
15 years old or older, but 65 years or younger
boolean
C0001779 (UMLS CUI [1])
karnofsky
Item
adequate performance status (karnofsky score of 50 or more)
boolean
C0206065 (UMLS CUI [1])
hepatic and renal function
Item
adequate hepatic and renal function (ast, alt, bilirubin and creatinine < 2.5 x upper normal limit). elevation of ast or alt due to hepatic infiltration of leukemic cells will be permitted.
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
cardiac function
Item
adequate cardiac function (left ventricular ejection fraction of 45% or more on heart scan or echocardiogram)
boolean
C0428772 (UMLS CUI [1])
informed consent
Item
signed and dated informed consent must be obtained
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
APL
Item
patients with acute promyelocytic leukemia or bcr-abl gene rearrangement
boolean
C0023487 (UMLS CUI [1])
cns leukemia
Item
patients with cns leukemia
boolean
C1332884 (UMLS CUI [1])
granulocytic sarcoma
Item
patients with primary granulocytic sarcoma without bone marrow involvement
boolean
C0152276 (UMLS CUI [1])
chemotherapy
Item
prior chemotherapy for leukemia or anthracycline treatment for any malignancy. hydroxyurea for reduction of leukemic cell burden before induction chemotherapy will be permitted.
boolean
C0392920 (UMLS CUI [1])
infection
Item
presence of significant active infection
boolean
C0009450 (UMLS CUI [1])
bleeding
Item
presence of uncontrolled bleeding
boolean
C0019080 (UMLS CUI [1])
heart disease
Item
significant cardiovascular disease including myocardial infarction within previous 6 months
boolean
C0018799 (UMLS CUI [1])
comorbidity
Item
any coexisting major illness or organ failure
boolean
C0009488 (UMLS CUI [1])
patients with psychiatric disorder or mental deficiency severe as to make compliance with the treatment unlike, and making informed consent impossible
Item
patients with psychiatric disorder or mental deficiency severe as to make compliance with the treatment unlike, and making informed consent impossible
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
pregnancy or lactation, contraception
Item
nursing women, pregnant women, women of childbearing potential who do not want adequate contraception
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
malignancy
Item
patients with a diagnosis of prior malignancy unless disease-free for at least 5 years following therapy with curative intent (except curatively treated nonmelanoma skin cancer, in situ carcinoma, or cervical intraepithelial neoplasia)
boolean
C0006826 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial